Skip to main content

Advertisement

Log in

Is Use of PPIs Related to Increased Intraepithelial Lymphocytes in the Colon?

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

The use of proton pump inhibitors (PPIs) is thought to increase the incidence of microscopic colitis (MC), although the exact mechanisms are not fully understood. Increased infiltration of intraepithelial lymphocytes (IELs) is a pathologic finding of MC (including collagenous or lymphocytic colitis).

Aims

We investigated whether PPI use is associated with increased IEL infiltration and inflammation in the lamina propria.

Methods

We retrospectively reviewed the medical records and histological reports of 78 patients receiving PPIs who had no symptoms of diarrhea, and their age- and gender- matched controls. The levels of IELs and inflammation in the lamina propria were assessed independently by two pathologists using H&E and immunohistochemical staining for CD3 and CD8.

Results

The IEL count was significantly higher in the PPI group than in controls (12.92 ± 6.27 vs. 8.10 ± 4.21 per 100 epithelial cells, p < 0.001), as was the extent of inflammation (1.74 ± 0.90 vs. 0.86 ± 0.78, p < 0.001). PPI use was associated with increased IEL infiltration in a multivariate analysis (OR, 3.232; 95 % CI, 1.631–6.404, p < 0.001). Within the PPI group, however, the IEL count was not significantly associated with gender, age, type of PPI, or duration of PPI use.

Conclusions

The use of PPIs has a significant association with increased IEL infiltration for subjects without symptoms of diarrhea. This finding suggests that changes such histological alterations seen in the early phage seen in MC possibly represent the stage of the disease even before the onset of symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Warren BF, Edwards CM, Travis SP. ‘Microscopic colitis’: classification and terminology. Histopathology. 2002;40:374–376.

    Article  PubMed  CAS  Google Scholar 

  2. Lazenby AJ, Yardley JH, Giardiello FM, Jessurun J, Bayless TM. Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989;20:18–28.

    Article  PubMed  CAS  Google Scholar 

  3. Olesen M, Eriksson S, Bohr J, Jarnerot G, Tysk C. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut. 2004;53:346–350.

    Article  PubMed  CAS  Google Scholar 

  4. Pardi DS, Loftus EV Jr, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007;56:504–508.

    Article  PubMed  Google Scholar 

  5. Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.

    Article  PubMed  Google Scholar 

  6. Nomura E, Kagaya H, Uchimi K, et al. Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis. Endoscopy. 2010;42:E9–E10.

    Article  PubMed  Google Scholar 

  7. Yusuke H, Jun T, Naotaka M, Yuichi T, Yutaka E, Kazuaki I. Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis. Endoscopy. 2009;41:E281–E282.

    Article  PubMed  Google Scholar 

  8. Umeno J, Matsumoto T, Nakamura S, et al. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis. Gastrointest Endosc. 2008;67:1185–1191.

    Article  PubMed  Google Scholar 

  9. Wilcox GM, Mattia AR. Microscopic colitis associated with omeprazole and esomeprazole exposure. J Clin Gastroenterol. 2009;43:551–553.

    Article  PubMed  CAS  Google Scholar 

  10. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336:2–3.

    Article  PubMed  Google Scholar 

  11. Dobbins WO 3rd. Human intestinal intraepithelial lymphocytes. Gut. 1986;27:972–985.

    Article  PubMed  Google Scholar 

  12. Chung SJ, Kim SG, Jung HC, Song IS, Kim JS. Clinical practice patterns of gastroenterologists for initial and maintenance therapy in gastroesophageal reflux disease: a nationwide online survey in Korea. Korean J Gastroenterol. 2009;54:364–370.

    Article  PubMed  Google Scholar 

  13. Mullin JM, Gabello M, Murray LJ, et al. Proton pump inhibitors: actions and reactions. Drug Discov Today. 2009;14:647–660.

    Article  PubMed  CAS  Google Scholar 

  14. Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 2002;123:433–443.

    Article  PubMed  Google Scholar 

  15. Lewis SJ, Franco S, Young G, O’Keefe SJ. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557–561.

    Article  PubMed  CAS  Google Scholar 

  16. Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol. 2007;60:382–387.

    Article  PubMed  CAS  Google Scholar 

  17. Nyhlin N, Bohr J, Eriksson S, Tysk C. Systematic review: microscopic colitis. Aliment Pharmacol Ther. 2006;23:1525–1534.

    Article  PubMed  CAS  Google Scholar 

  18. Sylwestrowicz T, Kelly JK, Hwang WS, Shaffer EA. Collagenous colitis and microscopic colitis: the watery diarrhea-colitis syndrome. Am J Gastroenterol. 1989;84:763–768.

    PubMed  CAS  Google Scholar 

  19. van Tilburg AJ, Lam HG, Seldenrijk CA, et al. Familial occurrence of collagenous colitis. A report of two families. J Clin Gastroenterol. 1990;12:279–285.

    Article  PubMed  Google Scholar 

  20. Bohr J. A review of collagenous colitis. Scand J Gastroenterol. 1998;33:2–9.

    Article  PubMed  CAS  Google Scholar 

  21. Mulder CJ, Harkema IM, Meijer JW, De Boer NK. Microscopic colitis. Rom J Gastroenterol. 2004;13:113–117.

    PubMed  Google Scholar 

  22. Camarero C, Leon F, Colino E, et al. Collagenous colitis in children: clinicopathologic, microbiologic, and immunologic features. J Pediatr Gastroenterol Nutr. 2003;37:508–513.

    Article  PubMed  CAS  Google Scholar 

  23. Mahajan L, Wyllie R, Goldblum J. Lymphocytic colitis in a pediatric patient: a possible adverse reaction to carbamazepine. Am J Gastroenterol. 1997;92:2126–2127.

    PubMed  CAS  Google Scholar 

  24. Keszthelyi D, Jansen SV, Schouten GA, et al. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther. 2010;32:1124–1128.

    Article  PubMed  CAS  Google Scholar 

  25. Capurso G, Marignani M, Attilia F, et al. Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospective case-series and systematic review of the literature. Dig Liver Dis. 2011;43:380–385.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This work was supported by the research fund of Hanyang University (HY2010-MC).

Conflict of interest

The authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dong Soo Han.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, Y.H., Han, D.S., Choi, E.Y. et al. Is Use of PPIs Related to Increased Intraepithelial Lymphocytes in the Colon?. Dig Dis Sci 57, 2669–2674 (2012). https://doi.org/10.1007/s10620-012-2315-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2315-0

Keywords

Navigation